−0.0155EUR
−847.37 KEUR
2.33 MEUR
46.82 M
About ALPHAHELIX MOLECULAR DIAGNOSTICS AB
Sector
Industry
CEO
Joakim Grånemo
Website
Headquarters
Nacka
Employees (FY)
13
Founded
1998
ISIN
SE0000885501
FIGI
BBG010S1SPG2
AlphaHelix Molecular Diagnostics AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ALPHAHELIX MOL.DIAGN. SK1 stocks are traded under the ticker 4MB.
Yes, you can track ALPHAHELIX MOL.DIAGN. SK1 financials in yearly and quarterly reports right on TradingView.
4MB net income for the last quarter is −212.51 K EUR, while the quarter before that showed −380.94 K EUR of net income which accounts for 44.22% change. Track more ALPHAHELIX MOL.DIAGN. SK1 financial stats to get the full picture.
No, 4MB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4MB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALPHAHELIX MOL.DIAGN. SK1 stock right from TradingView charts — choose your broker and connect to your account.
As of May 12, 2024, the company has 13.00 employees. See our rating of the largest employees — is ALPHAHELIX MOL.DIAGN. SK1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALPHAHELIX MOL.DIAGN. SK1 EBITDA is −858.69 K EUR, and current EBITDA margin is −31.49%. See more stats in ALPHAHELIX MOL.DIAGN. SK1 financial statements.